NEW YORK, Nov 21 – Structural Bioinformatics of San Diego said Tuesday it had licensed its SBdBase database of 3-dimensional protein structures to De Novo Pharmaceuticals.

Under the terms of the deal, De Novo will have access to multiple therapeutic target classes, Structural Bioinformatics said in a statement.

Financial terms were not disclosed.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

American scientists find themselves once again warning the Trump administration not to dismiss science, the New Yorker report.

A new study suggests CRISPR could be used to save coral reefs from dying off, Forbes reports.

Researchers have found that the i-motif shape of DNA previously observed in the lab also exists in human cells, and that it may serve a purpose.

In PNAS this week: a genomic, transcriptomic, and metabolomic analysis of the tea plant, Arabidopsis thaliana's adaptations to specific local environments, and more.